Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Pharmaceutical Industries (NPI) is a leading pharmaceutical manufacturer based in the Sultanate of Oman and was the first pharmaceutical plant established in the country. The company focuses on the development, manufacturing, and marketing of a wide range of generic pharmaceutical products across various therapeutic segments, including anti-infectives, cardiovascular, central nervous system, and endocrine systems. NPI operates state-of-the-art manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards, enabling it to supply high-quality medicines to the GCC region and international markets. In addition to its own product portfolio, the company provides contract manufacturing services to global pharmaceutical partners. NPI is publicly traded on the Muscat Stock Exchange and plays a critical role in the regional healthcare infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NPI Pharmaceuticals.